Alpha Profiles · Company Profile

FATE THERAPEUTICS INC

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/fate-therapeutics-inc

Entity: Public listing published
Primary listing: NASDAQ: FATE
Verification: Partially verified
Last reviewed: 2026-10-14T04:46:35.537539+00:00

Overview

Alpha's canonical identity and public leadership record for FATE THERAPEUTICS INC.

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

3 public records

Bahram Valamehr

President, Chief Executive Officer, Chief Research and Development Officer and Director

State: confirmed
Effective: From Apr 24, 2026
Confidence: 94%
Evidence: FATE DEF 14A executive officersApr 24, 2026

Cindy R. Tahl

Chief Legal Compliance Officer and Corporate Secretary

State: confirmed
Effective: From Apr 24, 2026
Confidence: 94%
Evidence: FATE DEF 14A executive officersApr 24, 2026

Kamal Adawi

Chief Financial Officer and Treasurer

State: confirmed
Effective: From Apr 24, 2026
Confidence: 94%
Evidence: FATE DEF 14A executive officersApr 24, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Oct 14, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.